Ellison Institute researchers and scientists will be participating in the AACR Annual Meeting in New Orleans, LA from April 8-13, 2022. This meeting brings together scientists, health care professionals, survivors, patients, and advocates to highlight and discuss the latest advances in cancer science and medicine.
Read on to explore the areas where Institute staff will be joining the conversation and sharing their work, and click the link below to register to attend the conference virtually where possible.
|Details||EI Staff & Event|
1:30 – 5PM CT
Dr. Weikun Xiao (presenter), Mahsa Pahlavan, Bayan Mahgoub, Hanaa Knaneh, Dr. Reginald Hill: Increased extracellular matrix stiffness induces hypersecretion of chemoresistance-promoting cancer associated fibroblast-derived exosomes in pancreatic cancer. Abstract.
1:30 – 5PM CT
Scott Valena (presenter), Pratiksha Kshetri, Brandon Choi, Ah Young Yoon, Dr. Seungil Kim, Dr. Michael E. Doche, Dr. Shannon M. Mumenthaler: A quality-controlled patient-derived tumor organoid biobank facilitates applications such as an integrated database of chemotherapeutic drug response using deep learning-based imaging methods. Abstract.
9AM – 12:30PM CT
Dr. Mitchell Gross (co-author): Phase 1, first-in-human, dose-escalation study of oral TP-1287, a cyclin dependent kinase 9 (CDK9) inhibitor, in patients with advanced solid tumors. Abstract.
9AM – 12PM CT
Dr. Carly Strelez (presenter), Dr. Sujatha Chilakala, Kimya Ghaffarian, Ah Young Yoon, Dr. Jonathan Katz, Dr. Shannon M. Mumenthaler: Peristalsis-like mechanical stimuli in the intestinal milieu promotes colorectal cancer invasion through GABAergic signaling changes in an organ-on-chip platform. Abstract.
8 – 10AM CT
Plenary Session Intro & Wrap-up
Dr. Ann Barker (Chairperson): Plenary Session – Tumor Evolution and Therapeutic Resistance.
LIVE STREAM AVAILABLE.
|Scientist ↔ Survivor Program|
Dr. Ann Barker (Chair), Dr. Jerry Lee, Dr. Shannon M. Mumenthaler (Scientific Mentors): This global program pairs cancer scientists and researchers with survivors and advocates to build real partnerships that educate these communities and empower cancer patients.